share_log

Form 144 | 武田制药(TAK.US)关联方拟出售2.76万股股份,价值约36.38万美元

Form 144 | Takeda Pharmaceutical(TAK.US) Insider Proposes to Sell 363.81K in Common Stocks

Moomoo News ·  Jul 10 19:20

SEC FILLINGS DISCLOSED/ Jul 10, $Takeda Pharmaceutical (TAK.US)$$TAKEDA PHARMACEUTICAL CO LTD (TKPHF.US)$ Insider Lauren Rusckowski Duprey intends to sell 27,603 shares of its common stock on Jul 11, with a total market value of approximately $363.81K.

1720610424713095332.png

What is Form 144?

Form 144: Notice of Proposed Sale of Securities is a document issued by the Securities and Exchange Commission (SEC). Individuals such as executive officers and affiliates of a US-listed company must submit this form to the SEC when they intend to sell more than 5,000 shares or units of that company's stock, or if the sale price adds up to more than $50,000 in any three-month period. This regulation is known as Rule 144, under the Securities Act of 1933.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment